DUBLIN--(BUSINESS WIRE)--Sep 6, 2018--The "Global Overactive Bladder Treatment Market - Segmented by Therapy, Disease, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The global overactive bladder treatment market is expected to register a CAGR of about 2.9% over the forecast period 2018-2023.

Aging Population and Rising Incidence of Diseases Characterized by OAB

In 2017, there were approximately 950 million people who were 60 years old or above, comprising 13% of the global population, and is growing by about 3% every year. Incontinence generally increases with aging. As per a global population-based survey, the estimated prevalence of overactive bladder (OAB) in Europe and Canada was found to be 12.8% in women and 10.8% in men.OAB has a major negative impact on quality of life and health of the aged population. With the increasing burden of OAB, along with other urinary diseases, the growth of the overactive bladder treatment market is likely to be high.Other factors, such as the development of innovative intravesical therapies and aggressive marketing by pharmaceuticals companies, are also expected to expand the market.Notable HighlightsUndesired Systemic Effects of the Current OAB Treatments - Slowing GrowthNorth America to Dominate the MarketCompanies FeaturedAllergan PLCAstellas Pharma Inc.Cogentix Medical Inc.Endo International PLCHisamitsu Pharmaceutical Co. Inc.Johnson & JohnsonMedtronic PLCPfizer Inc.SanofiTeva Pharmaceutical Industries Limited

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/pcvd53/global_overactive?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005434/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Urological Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/06/2018 07:43 AM/DISC: 09/06/2018 07:43 AM

http://www.businesswire.com/news/home/20180906005434/en